Sec Form 4 Filing - ROOT JONATHAN D @ Inari Medical, Inc. - 2021-05-13

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
ROOT JONATHAN D
2. Issuer Name and Ticker or Trading Symbol
Inari Medical, Inc. [ NARI]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
1460 EL CAMINO REAL, SUITE 100
3. Date of Earliest Transaction (MM/DD/YY)
05/13/2021
(Street)
MENLO PARK, CA94025
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 05/13/2021 J( 1 ) 2,619,872 D 0 I Directly owned by USVP X ( 2 )
Common Stock 05/13/2021 J( 1 ) 83,813 D 0 I Directly owned by AFF X ( 2 )
Common Stock 05/13/2021 J( 1 ) 685,826 A 685,826 I Directly owned by PMG X ( 3 )
Common Stock 05/13/2021 J( 1 ) 685,826 D 0 I Directly owned by PMG X ( 4 )
Common Stock 05/13/2021 J( 1 ) 93,972 A 521,864 D ( 5 )
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exerci sable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
ROOT JONATHAN D
1460 EL CAMINO REAL
SUITE 100
MENLO PARK, CA94025
X
Signatures
Dale Holladay, Attorney in Fact for the Reporting Person 05/17/2021
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Represents a pro-rata in-kind distribution of the Issuer's common stock, and not a purchase or sale, without additional consideration to their respective partners, members and assignees, as applicable.
( 2 )Represents a pro-rata in-kind distribution of the Issuer's common stock held directly by each of U.S. Venture Partners X, L.P. ("USVP X") and USVP X Affiliates Fund L.P. ("AFF X" and, together with USVP X, the "USVP X Funds"), without additional consideration, to its partners. Presidio Management Group X, L.L.C. ("PMG X") is the general partner of each of the USVP X Funds and may be deemed to have sole voting and dispositive power over the securities held by the USVP X Funds. The Reporting Person, a director of the Issuer, is a managing member of PMG X with additional rights with respect to such shares, and deemed to have sole voting and dispositive power over the reported securities held by the USVP X Funds, and disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein.
( 3 )Represents a pro-rata in-kind distribution of the Issuer's common stock to PMG X from each of the USVP X Funds, without additional consideration. The Reporting Person, a director of the Issuer, is a managing member of PMG X with additional rights with respect to the shares, and deemed to have sole voting and dispositive power over the reported securities held by PMG X, and disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein.
( 4 )Represents a pro-rata in-kind distribution of the Issuer's common stock held directly by PMG X, without additional consideration to its members (the "PMG Distribution"). The Reporting Person, a director of the Issuer, is a managing member of PMG X with additional rights with respect to the shares, and may be deemed to have sole voting and dispositive power over the reported securities held by PMG X, and disclaims beneficial ownership of such securities held by PMG X, except to the extent of any pecuniary interest therein.
( 5 )Represents a change in the form of ownership from indirect to direct by virtue of the receipt of shares in the PMG X Distribution. Shares are held directly by the Reporting Person.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.